Company intelligence / Profile preview

ProMD

Milan, Lombardy, Italy

Ownership: Private
Development stage: Other

Overview

ProMD (Professional Medical Devices) is an Italian biotechnology and medical device company specializing in regenerative medicine and autologous cell therapies. The company is best known for its proprietary ProMD Platelet-Rich Plasma (PRP) system, which utilizes advanced centrifugation technology to concentrate growth factors and bioactive proteins from a patient's own blood. Their products are widely used across orthopedic surgery, sports medicine, dermatology, and aesthetic medicine to accelerate tissue repair and reduce inflammation. ProMD focuses on providing high-purity, standardized biological concentrates that support natural healing processes in various clinical settings.

Therapeutic areas: RheumatologyDermatology
Modalities: Cell therapyBiologicDevice
Industry: Biotech

Beyond the preview

Go deeper on ProMD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProMD.

Explore the full profile